Compare Charles River Laboratories Intl. Inc (CRL) vs HSBC Holdings plc (HSBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs HSBC Holdings plc — how do they compare? Charles River Laboratories Intl. Inc trades at $287.99 (market cap $13.46B), while HSBC Holdings plc trades at $104.04 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 26.3× Charles River Laboratories Intl. Inc's market cap, and HSBC Holdings plc pays a 3.63% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | HSBC | |
|---|---|---|
Market Cap | $13.46B | $353.82B |
Sector | Health | Technology |
52-Week High | $282.00 | $107.86 |
52-Week Low | $145.57 | $63.84 |
Enterprise Value | $16.30B | — |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →
